73 related articles for article (PubMed ID: 9132749)
21. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
Davies AM; Chansky K; Lau DH; Leigh BR; Gaspar LE; Weiss GR; Wozniak AJ; Crowley JJ; Gandara DR;
J Clin Oncol; 2006 Nov; 24(33):5242-6. PubMed ID: 17114656
[TBL] [Abstract][Full Text] [Related]
22. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
[TBL] [Abstract][Full Text] [Related]
23. A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956).
Scagliotti GV; Smit E; Bosquee L; O'Brien M; Ardizzoni A; Zatloukal P; Eberhardt W; Smid-Geirnaerdt M; de Bruin HG; Dussenne S; Legrand C; Giaccone G;
Lung Cancer; 2005 Oct; 50(1):91-6. PubMed ID: 16019107
[TBL] [Abstract][Full Text] [Related]
24. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of carboplatin and weekly paclitaxel combination chemotherapy in advanced non-small cell lung cancer: a Kansai Clinical Oncology Group study.
Hirabayashi M; Endoh K; Teramachi M; Okuda M; Yamaguchi K; Fukuda K; Tokuhisa H; Kagioka H; Nakai N; Nakade M
Lung Cancer; 2004 Jun; 44(3):355-62. PubMed ID: 15140549
[TBL] [Abstract][Full Text] [Related]
26. Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer.
Choy H; Safran H; Akerley W; Graziano SL; Bogart JA; Cole BF
Clin Cancer Res; 1998 Aug; 4(8):1931-6. PubMed ID: 9717821
[TBL] [Abstract][Full Text] [Related]
27. Measurement and impact of co-morbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel.
Juan O; Albert A; Campos JM; Caranyana V; Muñoz J; Alberola V
Acta Oncol; 2007; 46(3):367-73. PubMed ID: 17450473
[TBL] [Abstract][Full Text] [Related]
28. Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial.
Stathopoulos GP; Katis C; Tsavdaridis D; Dimitroulis J; Karaindros D; Stathopoulos J; Dimou E
Cancer Chemother Pharmacol; 2006 Oct; 58(4):555-60. PubMed ID: 16520987
[TBL] [Abstract][Full Text] [Related]
29. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
[TBL] [Abstract][Full Text] [Related]
30. [Early phase II study of BMS-181339 (paclitaxel) in patients with non-small cell lung cancer. BMS-181339 Non-Small Cell Lung Cancer Study Group].
Yoneda S; Nishiwaki Y; Niitani H; Kurita Y; Ariyoshi Y; Ikegami H; Furuse K; Fukuoka M; Kimura I; Hara N; Saijo N
Gan To Kagaku Ryoho; 1996 May; 23(6):695-701. PubMed ID: 8645020
[TBL] [Abstract][Full Text] [Related]
31. Single-agent paclitaxel as a 3-hour infusion.
Gatzemeier U; Neuhauss R; Schluter I; von Pawel J; Wagner H; Diergarten K
Semin Oncol; 1996 Dec; 23(6 Suppl 16):94-7. PubMed ID: 9007132
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of weekly paclitaxel in patients with non-small cell lung cancer who have failed previous treatments.
Yasuda K; Igishi T; Kawasaki Y; Kato K; Matsumoto S; Katayama S; Sako T; Shigeoka Y; Suyama H; Sugitani A; Yamamoto M; Hitsuda Y; Shimizu E
Oncology; 2004; 66(5):347-52. PubMed ID: 15331920
[TBL] [Abstract][Full Text] [Related]
33. Phase I trial of weekly paclitaxel in advanced lung cancer.
Akerley W; Glantz M; Choy H; Rege V; Sambandam S; Joseph P; Yee L; Rodrigues B; Wingate P; Leone L
J Clin Oncol; 1998 Jan; 16(1):153-8. PubMed ID: 9440737
[TBL] [Abstract][Full Text] [Related]
34. A feasibility study of 1-h paclitaxel infusion in patients with solid tumors.
Tsavaris N; Polyzos A; Kosmas C; Giannikos L; Gogas J
Cancer Chemother Pharmacol; 1997; 40(4):353-7. PubMed ID: 9225955
[TBL] [Abstract][Full Text] [Related]
35. Phase II trial of weekly paclitaxel in previously untreated advanced non-small-cell lung cancer.
Yasuda K; Igishi T; Kawasaki Y; Yamamoto M; Kato K; Matsumoto S; Kotani M; Sako T; Shigeoka Y; Sugitani A; Histuda Y; Shimizu E
Oncology; 2003; 65(3):224-8. PubMed ID: 14657596
[TBL] [Abstract][Full Text] [Related]
36. A phase I study of paclitaxel in combination with etoposide in patients with stage IIIB/IV non-small cell lung cancer (NSCLC).
Ukena D; Berg M; Leutz M; Zell L; Schlimmer P; Sybrecht GW
Lung Cancer; 1998 Jan; 19(1):31-6. PubMed ID: 9493138
[TBL] [Abstract][Full Text] [Related]
37. Phase II study with paclitaxel for the treatment of advanced inoperable non-small cell lung cancer.
Gatzemeier U; Heckmayr M; Neuhauss R; Schlüter I; Pawel JV; Wagner H; Dreps A
Lung Cancer; 1995 Jun; 12 Suppl 2():S101-6. PubMed ID: 7551941
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of 3-hour infusion of paclitaxel in patients with previously untreated stage III and IV non-small cell lung cancer. West Japan Lung Cancer Group.
Furuse K; Naka N; Takada M; Kinuwaki E; Kudo S; Takada Y; Yamakido M; Yamamoto H; Fukuoka M
Oncology; 1997; 54(4):298-303. PubMed ID: 9216854
[TBL] [Abstract][Full Text] [Related]
39. Risk of severe acute hypersensitivity reactions after rapid paclitaxel infusion of less than 1-h duration.
Tsavaris NB; Kosmas C
Cancer Chemother Pharmacol; 1998; 42(6):509-11. PubMed ID: 9788579
[TBL] [Abstract][Full Text] [Related]
40. [A case of advanced non-small-cell lung cancer responding remarkably to weekly chemotherapy with paclitaxel].
Kato K; Kawasaki Y; Yano S; Miyata M; Mikami M; Yasuda K; Hitsuda Y; Shimizu E
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1277-81. PubMed ID: 11579640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
